 |
| March 2019 |
Staving Off Diabetic Vision Loss With Statins
A new study published in JAMA Ophthalmology in January 2019 suggests that the use of statins in individuals with diabetes significantly decreases the risk of developing diabetic retinopathy, which is recognized to be a leading microvascular complication of diabetes. According to estimates, as many as 191 million people worldwide will develop the vision-threatening eye disorder by 2030. Read more.
|
|
|
Advertisement
 |
|
Study Spotlights Role of Omega-3s in Cardiovascular Risk
A study first published in October 2018 in the New England Journal of Medicine and recently highlighted in Diabetes in Control Media News explored the association between omega-3 fatty acid supplementation in patients with diabetes and the risk of a first serious cardiovascular event, such as transient ischemic attack, stroke, or nonfatal myocardial infarction. Here is more information. |
|
|
Does Human Insulin Control Blood Glucose, Cut Costs?
A new retrospective study featured in January 2019 in JAMA highlights a potential cost-savings solution. It is achieved by implementing a switch from the more expensive, newer insulin analogue to less costly human insulin while maintaining adequate control over blood glucose, as well as protecting patients from serious hypoglycemic events, in patients with diabetes. Here is more information.
|
|
|
Connect With U.S. Pharmacist
    |
|
|
|
|
